Showing results (231-240 of 369) with videos related to
Sort By:
Pageof 37
BMJ (Clinical Research Ed.)|September 20, 2019
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysisHuseyin Naci, Courtney Davis, Jelena Savović, et al.JAMA Network Open|January 22, 2025
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential CensoringTomer Meirson, Jonathan Ofer, Noa Zimhony-Nissim, et al.Current Oncology Reports|November 4, 2021
A New Generation of Vaccines in the Age of ImmunotherapyAlfredo Addeo, Alex Friedlaender, Elisa Giovannetti, et al.Frontiers in Oncology|July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung CancerEmilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.Anticancer Research|June 1, 2018
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for ChemotherapyGiuseppe L Banna, Andrea Camerini, Giuseppe Bronte, et al.Targeted Oncology|January 12, 2020
Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature ReviewMichele Porcu, Cinzia Solinas, Cristina Migali, et al.Anticancer Research|August 28, 2004
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbineVincenzo Dongiovanni, Alfredo Addeo, Alfredo Berruti, et al.JAMA Oncology|January 6, 2018
Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysisBinod Dhakal, Aniko Szabo, Saurabh Chhabra, et al.The Oncologist|October 18, 2017
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind TrialHiroaki Tsukuura, Masayuki Miyazaki, Tatsuya Morita, et al.Ecancermedicalscience|January 26, 2019
ReDO_DB: the repurposing drugs in oncology databasePan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.Pageof 37